Objective To assess the efficacy and safety of Yiqi Yangyin Huoxue therapy (YYHT) for the treatment of IgA nephropathy. Methods Databases articles about YYHT in treating IgAN patients were searched through February 20...Objective To assess the efficacy and safety of Yiqi Yangyin Huoxue therapy (YYHT) for the treatment of IgA nephropathy. Methods Databases articles about YYHT in treating IgAN patients were searched through February 2018. Comparisons were YYHT alone or YYHT in combination with western medicine as experimental intervention, and western medicine as the control. Randomized controlled trials (RCTs) were selected. Cochrane collaboration tool was used for assessing risk of bias to evaluate methodologies. RevMan 5.3 software was applied to analyze the data of included trials. Results A total of 21 studies involving 1473 patients were included. Meta-analysis results demonstrated that YYHT alone or YYHT in combination with western medicine were more efficacious than only western medicine in decreasing proteinuria [MD =-0.41, 95% CI (-0.53,-0.29), P < 0.00001] and the urine red blood cells [MD =-7.46, 95% CI (-9.28,-5.64), P < 0.00001]. There also showed improvement in the clinical total effective rate [OR = 2.78, 95% CI (2.14, 3.61), P < 0.00001] between the two groups. Some of the included trials did not report the adverse events. Conclusions Current evidence shows that YYHT can reduce proteinuria and urine red blood cells and improve the total efficacy rate. Since poor quality and publication bias of some included trials, more evidence-based medicine studies needed to define the role of YYHT in the treatment of IgAN.展开更多
Objective To observe the effect of Yangyin Yiqi Huoxue Lishui Compound (YYHLC) combined with intravitreal injection of conbercept in the treatment of diabetic macular edema. Methods Sixty patients (70 eyes)with diabet...Objective To observe the effect of Yangyin Yiqi Huoxue Lishui Compound (YYHLC) combined with intravitreal injection of conbercept in the treatment of diabetic macular edema. Methods Sixty patients (70 eyes)with diabetic macular edema were randomly assigned to treatment group (30 cases,36 eyes) and control group(30 cases,34 eyes) by random digit table.展开更多
目的:探讨益气养阴、活血祛浊法对2型糖尿病患者血管的保护作用及机制。方法:选取2017年5月-2020年5月北京中医药大学房山医院内分泌科病房和门诊的2型糖尿病患者60例。按随机数字表法将患者分为治疗组和对照组,每组30例。在常规糖尿病...目的:探讨益气养阴、活血祛浊法对2型糖尿病患者血管的保护作用及机制。方法:选取2017年5月-2020年5月北京中医药大学房山医院内分泌科病房和门诊的2型糖尿病患者60例。按随机数字表法将患者分为治疗组和对照组,每组30例。在常规糖尿病饮食及运动基础上,对照组给予常规西药降糖治疗,治疗组在对照组基础上加用益气降浊汤。比较两组临床疗效,并观察两组治疗前后中医症候积分、空腹血糖(FBG)、餐后2 h血糖(2 h PBG)、糖化血红蛋白(HbA1c)、同型半胱氨酸(Hcy)、超敏C反应蛋白(hs-CRP)、内皮素-1(ET-1)、血管内皮生长因子(VEGF)等指标的变化。结果:治疗组总有效率虽高于对照组,但差异无统计学意义(P>0.05)。治疗前,两组中医症候评分比较,差异无统计学意义(P>0.05);治疗后,两组中医症候评分均较治疗前改善,且治疗组优于对照组,差异均有统计学意义(P<0.05)。治疗前,两组FBG、2 h PBG、HbA1c、Hcy、hs-CRP、ET-1、VEGF比较,差异均无统计学意义(P>0.05);治疗后,两组FBG、2 h PBG、HbA1c、Hcy、hs-CRP、ET-1、VEGF均较治疗前下降,且治疗组均低于对照组,差异均有统计学意义(P<0.05)。结论:益气养阴、活血祛浊中药方剂益气降浊汤,能显著改善2型糖尿病患者临床症状,降低血糖,保护血管内皮功能,且未发现不良反应。展开更多
文摘Objective To assess the efficacy and safety of Yiqi Yangyin Huoxue therapy (YYHT) for the treatment of IgA nephropathy. Methods Databases articles about YYHT in treating IgAN patients were searched through February 2018. Comparisons were YYHT alone or YYHT in combination with western medicine as experimental intervention, and western medicine as the control. Randomized controlled trials (RCTs) were selected. Cochrane collaboration tool was used for assessing risk of bias to evaluate methodologies. RevMan 5.3 software was applied to analyze the data of included trials. Results A total of 21 studies involving 1473 patients were included. Meta-analysis results demonstrated that YYHT alone or YYHT in combination with western medicine were more efficacious than only western medicine in decreasing proteinuria [MD =-0.41, 95% CI (-0.53,-0.29), P < 0.00001] and the urine red blood cells [MD =-7.46, 95% CI (-9.28,-5.64), P < 0.00001]. There also showed improvement in the clinical total effective rate [OR = 2.78, 95% CI (2.14, 3.61), P < 0.00001] between the two groups. Some of the included trials did not report the adverse events. Conclusions Current evidence shows that YYHT can reduce proteinuria and urine red blood cells and improve the total efficacy rate. Since poor quality and publication bias of some included trials, more evidence-based medicine studies needed to define the role of YYHT in the treatment of IgAN.
文摘Objective To observe the effect of Yangyin Yiqi Huoxue Lishui Compound (YYHLC) combined with intravitreal injection of conbercept in the treatment of diabetic macular edema. Methods Sixty patients (70 eyes)with diabetic macular edema were randomly assigned to treatment group (30 cases,36 eyes) and control group(30 cases,34 eyes) by random digit table.
文摘目的:探讨益气养阴、活血祛浊法对2型糖尿病患者血管的保护作用及机制。方法:选取2017年5月-2020年5月北京中医药大学房山医院内分泌科病房和门诊的2型糖尿病患者60例。按随机数字表法将患者分为治疗组和对照组,每组30例。在常规糖尿病饮食及运动基础上,对照组给予常规西药降糖治疗,治疗组在对照组基础上加用益气降浊汤。比较两组临床疗效,并观察两组治疗前后中医症候积分、空腹血糖(FBG)、餐后2 h血糖(2 h PBG)、糖化血红蛋白(HbA1c)、同型半胱氨酸(Hcy)、超敏C反应蛋白(hs-CRP)、内皮素-1(ET-1)、血管内皮生长因子(VEGF)等指标的变化。结果:治疗组总有效率虽高于对照组,但差异无统计学意义(P>0.05)。治疗前,两组中医症候评分比较,差异无统计学意义(P>0.05);治疗后,两组中医症候评分均较治疗前改善,且治疗组优于对照组,差异均有统计学意义(P<0.05)。治疗前,两组FBG、2 h PBG、HbA1c、Hcy、hs-CRP、ET-1、VEGF比较,差异均无统计学意义(P>0.05);治疗后,两组FBG、2 h PBG、HbA1c、Hcy、hs-CRP、ET-1、VEGF均较治疗前下降,且治疗组均低于对照组,差异均有统计学意义(P<0.05)。结论:益气养阴、活血祛浊中药方剂益气降浊汤,能显著改善2型糖尿病患者临床症状,降低血糖,保护血管内皮功能,且未发现不良反应。
